Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Azacitidine in combination with venetoclax, gilteritinib, midostaurin or other compounds for treating leukemia or myelodysplastic syndrome

Azacitidine in combination with venetoclax, gilteritinib, midostaurin or other compounds for treating leukemia or myelodysplastic syndrome

US Patent 12447171 · Granted Oct 21, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CDC7 kinase inhibitors and uses thereof2024
Compositions and methods for preparing and using mitochondrial uncouplers2024
Substituted imidazo[4,5-b]pyridines, imidazo[4,5-b]pyrazines, and oxazolo[4,5- b2023
CDC7 kinase inhibitors and uses thereof2023
Treatment of a hematologic malignancy with 2-(4-chlorophenyl)-n-((2-(2,6-dioxopi2023
Antiproliferative compounds and methods of use thereof2022
Cdc7 kinase inhibitors and uses thereof2021
Methods for determining drug efficacy for the treatment of diffuse large B-cell 2021
Combination therapy for treating malignancies2020
Combination therapy for treating malignancies2020
Antibody drug conjugates2020
Treatment of a hematologic malignancy with 2-(4-chlorophenyl)-N-((2-(2,6-dioxopi2019